THERAPIX BIOSCIENCES LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
+27.78% | +53.33% |
| 02:26pm | Scisparc Signs Non-Binding Letter of Intent for Out-Licensing of Potential Pain Treatment | MT |
| 16/07 | SciSparc Receives Nasdaq Noncompliance Notice | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 45.35B | ||||||
| 24.34B | ||||||
| 16.51B | ||||||
| 14.6B | ||||||
| 14.27B |
